11/25
01:54 pm
mgrx
Mangoceuticals (NASDAQ:MGRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Mangoceuticals (NASDAQ:MGRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/22
02:11 am
mgrx
Mangoceuticals (NASDAQ:MGRX) was downgraded by analysts at
Wall Street Z
Medium
Report
Mangoceuticals (NASDAQ:MGRX) was downgraded by analysts at
Wall Street Z
11/22
02:11 am
mgrx
Mangoceuticals (NASDAQ:MGRX) was downgraded by analysts at
Wall Street Z
Medium
Report
Mangoceuticals (NASDAQ:MGRX) was downgraded by analysts at
Wall Street Z
11/18
01:18 pm
mgrx
Mangoceuticals (NASDAQ:MGRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Mangoceuticals (NASDAQ:MGRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/13
07:45 pm
mgrx
Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs [Yahoo! Finance]
High
Report
Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs [Yahoo! Finance]
11/13
07:37 pm
mgrx
Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs
High
Report
Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs
11/13
07:37 am
mgrx
Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs [Yahoo! Finance]
High
Report
Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs [Yahoo! Finance]
11/13
07:34 am
mgrx
Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs [Yahoo! Finance Canada]
High
Report
Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs [Yahoo! Finance Canada]
11/13
07:00 am
mgrx
Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management
High
Report
Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management
11/12
01:27 pm
mgrx
Mangoceuticals (NASDAQ:MGRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Mangoceuticals (NASDAQ:MGRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/3
03:40 pm
mgrx
Mangoceuticals (NASDAQ:MGRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Mangoceuticals (NASDAQ:MGRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.